Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Ronald W. Grane"'
Publikováno v:
Current Urology. 7:65-69
Background: Circulating tumor cells (CTC) predict overall survival in patients with metastatic prostate cancer. The objective of this study is to measure CTC before radical prostatectomy in intermediate- and high-risk prostate cancer patients. Materi
Autor:
Ronald W. Grane, Ana M. Gamero, Judith A. Drazba, Barbara S. Jacobs, Kevin A. Carnevale, Joseph A. Bauer, Sally Dabney, Daniel J. Lindner, Bellur Seetharam, Daniel J. Smith, Bei H. Morrison
Publikováno v:
CancerSpectrum Knowledge Environment. 94:1010-1019
Background The ubiquitous plasma membrane transcobalamin II receptor (TC II-R) mediates uptake of cobalamin (Cbl; vitamin B12), an essential micronutrient. Tumors often require more Cbl than normal tissue, and increased Cbl uptake may result from inc
Autor:
Barbara S. Jacobs, Ernest C. Borden, Daniel J. Lindner, Joseph A. Bauer, Bei H. Morrison, Ronald W. Grane
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 23(1)
Angiogenesis is an absolute requirement for tumor growth and metastasis. The purpose of this study was to evaluate the antiangiogenic activity of interferon-alpha2b (IFN-alpha2b) and thalidomide, as single agents and in combination. The murine dermis
Autor:
Alexandru Almasan, Mamta Chawla-Sarkar, Joseph A. Bauer, Aylin M. Ozdemir, Jiadi Hu, Dhananjaya V. Kalvakolanu, Bendi Gong, Daniel J. Lindner, Bei H. Morrison, Ronald W. Grane
Publikováno v:
Oncogene. 21(12)
We recently identified inositol hexakisphosphate kinase 2 (IP6K2) as a positive regulator of apoptosis. Overexpression of IP6K2 enhances apoptosis induced by interferon-beta (IFN-beta) and cytotoxic agents in NIH-OVCAR-3 ovarian carcinoma cells. In t
Autor:
Ernest C. Borden, Paul Elson, Nooshin Hashemi Sadraei, John Hamulak, Nathan A. Pennell, Patrick C. Ma, Lingling Du, Ronald W. Grane, Ruchi Yadav, Barbara S. Jacobs
Publikováno v:
Journal of Clinical Oncology. 31:e19012-e19012
e19012 Background: Bev in combination with chemotherapy (CT) is a standard treatment for pts with stage IV NSCLC. However, there are no established biomarkers to improve benefit-to-risk profile of therapy. CEC are a marker of vascular turnover. We hy
Autor:
Ernest C. Borden, Ronald W. Grane, Arun D. Singh, Susan Achberger, Pierre L. Triozzi, Wayne Aldrich
Publikováno v:
Journal of Translational Medicine
Journal of Translational Medicine, Vol 10, Iss 1, p 241 (2012)
Journal of Translational Medicine, Vol 10, Iss 1, p 241 (2012)
Background Blood biomarkers are needed to monitor anti-angiogenic treatments for cancer. The association of blood levels of microRNAs (miRs) implicated in angiogenesis with circulating endothelial cells (CEC) and with angiogenic proteins was examined
Publikováno v:
The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society. 35(4)
Two-micrometer sections of methacrylate-embedded kidney were used to investigate the enzymatic activities of mouse kidney where the proximal tubule and Bowman's capsule from the same corpuscle were viewed in the same section. Alkaline phosphatase, ac